Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
02/2004
02/18/2004CN1138535C Pharmaceutical compositions contg. effervescent acid -base couple
02/12/2004WO2003010159A8 Piperidine derivatives as nmda receptor antagonists
02/12/2004US20040029927 Oral administering of tablet of triprolidine
02/10/2004US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones
02/10/2004US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same
02/05/2004WO2003080580A3 Quinoline derivatives and their use as 5-ht6 ligands
02/05/2004US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
02/05/2004US20040023955 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
02/05/2004US20040023898 Single dose azithromycin
02/04/2004EP1386921A1 Intermediates
02/04/2004EP1386917A1 Intermediates
02/04/2004EP1386912A1 Cyclic amidine derivative
02/04/2004EP1386909A1 Cyclopropane amines
02/04/2004CN1473051A Use of immidazoquinolinamines as adjuvants in DNA vaccination
01/2004
01/29/2004US20040018257 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
01/28/2004CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives
01/22/2004US20040014767 Central nervous system diosrders; antidepressants, anxiolytic agents, anxiolytic agents
01/22/2004US20040014708 Composition comprising immunogenic microparticles
01/21/2004CN1135112C Medicine for curing emmeniopathy and its preparation method
01/20/2004US6680329 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
01/20/2004US6680074 Potent antiviral, antibacterial or antimycotic activity
01/14/2004EP1380301A1 Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive
01/14/2004EP1379203A1 Condom with an erectogenic composition
01/14/2004EP1222195B1 Novel thiazolo(4,5-d)pyrimidine compounds
01/14/2004CN1468308A Anti-tnf antibodies, compositions, methods and uses
01/14/2004CN1468249A Methods and compositions for treating flaviviruses and pestiviruses
01/13/2004US6677455 Potassium salt of S-omeprazole
01/13/2004US6677336 Substituted piperazine compounds
01/08/2004WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors
01/08/2004WO2002059124A3 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
01/08/2004CA2490138A1 Novel tetrahydropyridine derivatives as renin inhibitors
01/07/2004EP1377556A1 Pyrazole derivatives for treating hiv
01/06/2004US6673833 As antitumor agent
01/06/2004US6673810 Anticoagulants
01/02/2004EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
01/02/2004EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
01/02/2004EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
12/2003
12/31/2003WO2004000366A1 Pegylated factor vii glycoforms
12/31/2003WO2004000341A1 The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof
12/31/2003WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003WO2003072576A3 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
12/31/2003WO2002047708A3 Selective cox-2 inhibition from edible plant extracts
12/31/2003CN1463735A Drug rehabilitation oral liquid
12/31/2003CN1132837C 螺呋喃并吡啶芳烷基胺、其制法和中间体及其药物组合物和制药用途 Spiro furopyridine arylalkylamines, their preparation and intermediates and pharmaceutical compositions thereof and pharmaceutical use
12/31/2003CA2490684A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
12/31/2003CA2490360A1 Pegylated factor vii glycoforms
12/31/2003CA2490100A1 Pharmaceutical formulation for use in treating drug withdrawal and preparation method
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/24/2003DE10225635C1 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung N-Benzoylureido-cinnamic acid derivatives, processes for their preparation and their use
12/24/2003CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof
12/24/2003CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate
12/23/2003US6667332 Benzisoxazolyl-pyrazole derivatives formed by salt formation with maleic acid and hydrochloric acid and cyclization with acetohydroxamic acid
12/18/2003WO2003104208A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104207A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/18/2003WO2003104188A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/18/2003WO2003039677A3 Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
12/18/2003US20030232814 Novel compounds and their use
12/18/2003CA2488760A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/17/2003CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/11/2003US20030229031 13-Methyl erythromycin derivatives
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/09/2003US6660866 C10 carbonate substituted taxanes
12/09/2003US6660304 Method of treating prickly heat
12/04/2003WO2003099786A2 Aromatic sulfones and their medical use
12/04/2003WO2003099281A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes
12/04/2003CA2486962A1 Compounds
12/03/2003EP1366045A2 Efficient process for the preparation of a factor xa inhibitor
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
11/2003
11/27/2003WO2003097636A1 Novel compounds and their use
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220358 A1 adenosine receptro antagonists
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003CA2483619A1 Novel compounds and their use
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363650A2 AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING i PIMENTA /i EXTRACT
11/26/2003EP1363627A2 Treatment of solid tumours with rapamycin derivatives
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003CN1128801C Triazolo (4,5-D) pyrimidine compounds
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/20/2003WO2003095470A1 Platinum complexes having antitumor activity
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003CA2485431A1 Platinum complexes having antitumor activity
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1214076B1 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003US20030212145 Parkinson's disease; cognition activators; central nervous system disorders
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212026 Induce immunology response
11/12/2003EP1360187A1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias
11/06/2003WO2002018369A8 Peptidomimetic protease inhibitors
11/06/2003US20030207920 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
11/05/2003EP1358213A2 Humanized antibodies that recognize beta amyloid peptide
11/05/2003EP1268468B1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs
11/05/2003EP0994713B1 USE OF A 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS
11/05/2003EP0699073B1 xenogeneic transplantation
11/05/2003CN1454096A Activity of extract of piper betle leaves against leishmania
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 32